SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028340
Filing Date
2016-11-08
Accepted
2016-11-08 16:15:39
Documents
59
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbyl-10q_20160930.htm 10-Q 1166259
2 EX-31.1 cbyl-ex311_8.htm EX-31.1 11737
3 EX-31.2 cbyl-ex312_6.htm EX-31.2 11155
4 EX-32.1 cbyl-ex321_7.htm EX-32.1 8716
  Complete submission text file 0001564590-16-028340.txt   4276526

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbyl-20160930.xml EX-101.INS 667583
6 XBRL TAXONOMY EXTENSION SCHEMA cbyl-20160930.xsd EX-101.SCH 42538
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbyl-20160930_cal.xml EX-101.CAL 33084
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbyl-20160930_def.xml EX-101.DEF 148286
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbyl-20160930_lab.xml EX-101.LAB 325872
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbyl-20160930_pre.xml EX-101.PRE 257259
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36830 | Film No.: 161981461
SIC: 2834 Pharmaceutical Preparations